4//SEC Filing
Fitzgerald Richard F 4
Accession 0001209191-20-053654
CIK 0001472012other
Filed
Oct 4, 8:00 PM ET
Accepted
Oct 5, 4:40 PM ET
Size
7.9 KB
Accession
0001209191-20-053654
Insider Transaction Report
Form 4
Immunome Inc.IMNM
Fitzgerald Richard F
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2020-10-01+7,681→ 7,681 totalExercise: $12.00Exp: 2030-10-01→ Common Stock (7,681 underlying) - Award
Employee Stock Option (right to buy)
2020-10-01+104,802→ 104,802 totalExercise: $12.00Exp: 2030-10-01→ Common Stock (104,802 underlying)
Footnotes (2)
- [F1]Twenty-five percent (25%) of the shares subject to the option shall vest on October 1, 2021, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
- [F2]The shares subject to the option shall vest on October 1, 2025, subject to the Reporting Person continuing to provide service through each such date.
Documents
Issuer
Immunome Inc.
CIK 0001472012
Entity typeother
Related Parties
1- filerCIK 0001459933
Filing Metadata
- Form type
- 4
- Filed
- Oct 4, 8:00 PM ET
- Accepted
- Oct 5, 4:40 PM ET
- Size
- 7.9 KB